Background Historically, axillary clearance with axillary lymph node dissection (ALND) was
important for the regional control of breast cancer. However, with increasing rates of early …

Background Lymphovascular invasion (LVI) status facilitates the selection of optimal
therapeutic strategy for breast cancer patients, but in clinical practice LVI status is …

Über viele Jahrzehnte war die komplette Ausräumung der axillären Lymphknoten im Sinne
einer Axilladissektion ein Standardverfahren in der Therapie des Mammakarzinom. Die …

Introduction Improving the early prediction of neoadjuvant chemotherapy (NAC) efficacy in
breast cancer can lead to an improved prediction of the final prognosis of patients, which …

Background The standard of care for breast cancer patients treated with neoadjuvant
chemotherapy (NAC) who have a positive sentinel lymph node (+ SLN) after NAC is …

Background When a positive sentinel lymph node (SLN) is identified after neoadjuvant
chemotherapy (NAC), completion axillary lymph node dissection (cALND) is generally …

Aim To assess the rate of positive non-sentinel lymph nodes (non-SLNs) after neoadjuvant
systemic therapy (NAST) in breast cancer (BC) following positive sentinel lymph node …

Our aim was to develop a tool to accurately predict the possibility of non-sentinel lymph
node metastasis (NSLNM) during surgery so that a surgeon might decide the extent of …

Abstract Background and Objectives This study mainly explored the factors that influence
non–sentinel lymph node (NSLN) metastasis in patients with breast cancer (BC) whose …

Purpose Few models with good discriminative power have been introduced to predict the
risk of non-sentinel lymph node (non-SLN) metastasis in breast cancer after neoadjuvant …